Related Experiment Video
Updated: Jun 3, 2026

Gastrointestinal Motility Monitor (GIMM)
Published on: December 1, 2010
Slow-transit constipation with concurrent upper gastrointestinal dysmotility and its response to transcutaneous
Yee Ian Yik1, Melanie C C Clarke, Anthony G Catto-Smith
1F Douglas Stephens Surgical Research and Gut Motility Laboratories, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Melbourne, VIC, 3052, Australia. yiyik@um.edu.my
Transcutaneous electrical stimulation (TES) benefits children with slow-transit constipation (STC). However, concurrent upper gastrointestinal dysmotility (UGD) may slightly reduce the effectiveness of TES in improving colonic transit.
Area of Science:
- Pediatric Gastroenterology
- Gastrointestinal Motility Disorders
- Neuromodulation Therapies
Background:
- Slow-transit constipation (STC) is a common condition in children.
- Transcutaneous electrical stimulation (TES) has shown promise in accelerating colonic transit in pediatric STC.
- The impact of concurrent upper gastrointestinal dysmotility (UGD) on TES response in STC is not well understood.
Purpose of the Study:
- To evaluate the efficacy of TES in children with STC.
- To determine if the presence of UGD influences the response to TES in children with STC.
Main Methods:
- A randomized controlled trial involving radio-nuclear transit studies (NTS) before and after TES treatment for STC.
- UGD was diagnosed based on delayed gastric emptying and/or slow small bowel transit.
- Treatment response was measured by an increase in Geometric Centre (GC) of ≥1.
Main Results:
- Active TES significantly increased colonic transit in over 50% of subjects compared to 25% with sham stimulation (p=0.04).
- Children with STC and normal upper GI motility (NUGM) showed a significantly greater increase in mean transit rate compared to those with UGD.
- While NTS improved in both groups with STC, the magnitude of improvement was less pronounced in children with UGD.
Conclusions:
- TES is a beneficial treatment for STC in children.
- The response to TES in STC may be weakly associated with the presence of UGD.
- Further research with larger cohorts is needed to definitively establish the clinical significance of UGD on TES efficacy in STC.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Gastrointestinal Motility Disorders